The long-term course of alcoholism, 5, 10 and 16 years after treatment.
- Authors
- Mann, Karl; SchΓ€fer, Dorothee R; LΓ€ngle, Gerhard; Ackermann, Klaus; Croissant, Bernhard
- Year
- 2005
- Journal
- Addiction (Abingdon, England)
- PMID
- 15918810
- DOI
- 10.1111/j.1360-0443.2005.01065.x
AIMS: To discover the long-term stability of drinking behaviour following an in-patient treatment episode. DESIGN: Three follow-up periods were used at 5, 10 and 16 years. The patients were classified as being abstinent, improved or unimproved on the basis of self-reported drinking behaviour. Patients who could not be interviewed at follow-up were classified as unimproved. SETTING: An alcohol dependence treatment programme at the University Hospital Tuebingen, Germany. PARTICIPANTS: We were able to locate all 96 patients at the 16-year follow-up. Seventy were alive and 26 had died. We collected information from 59 of the 70 surviving patients. The remaining 11 patients could be located and were definitely alive. FINDINGS: Thirty-eight of the 70 patients were abstinent, 10 were improved and 22 (including the 11 living patients without further information) were classified as unimproved. Our main finding indicates that the so-called 'improved drinking' is very inconsistent over time. In contrast, the abstinent and unimproved patients were much more stable in their drinking behaviour. CONCLUSIONS: This study extends our knowledge of the drinking trajectory and outcome from only a few years of follow-up to 16 years. Complete abstinence and unimproved drinking behaviour were the most stable drinking patterns observed over the long term, confirming study results obtained primarily from English-speaking countries.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Effectiveness of Disulfiram as Adjunct to Addiction-Focused Treatment for Persons With Severe Alcohol Use Disorder. | Schallenberg M et al. | β | 2025 | β |
| New Approaches to Addiction Treatment Based on Learning and Memory. | Bach P et al. | β | 2025 | β |
| Palliative care for people with substance use disorders: a qualitative study of the experiences of rural primary care providers. | Tayba L et al. | β | 2025 | β |
| The impact of organisational factors on treatment outcomes for those seeking alcohol or other drug treatment: A systematic review. | Hobden B et al. | β | 2023 | β |
| Patterns of Alcohol Consumption Among Individuals With Alcohol Use Disorder During the COVID-19 Pandemic and Lockdowns in Germany. | Deeken F et al. | β | 2022 | β |
| Alcohol dependence severity determines the course of treatment-seeking patients. | Yoshimura A et al. | β | 2021 | β |
| Addiction Research Consortium: Losing and regaining control over drug intake (ReCoDe)-From trajectories to mechanisms and interventions. | Heinz A et al. | β | 2020 | β |
| Palliative care for patients with substance use disorder and multiple problems: a qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience. | Ebenau A et al. | β | 2020 | β |
| Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder. | Barbosa C et al. | β | 2019 | β |
| Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON). | Malone M et al. | β | 2019 | β |
| Palliative care for people with substance use disorder and multiple problems: a qualitative study on experiences of patients and proxies. | Ebenau A et al. | β | 2019 | β |
| A 22-Year Follow-Up (Range 16 to 23) of Original Subjects with Baseline Alcohol Use Disorders from the Collaborative Study on Genetics of Alcoholism. | Schuckit MA et al. | β | 2018 | β |
| Palliative care for patients with a substance use disorder and multiple problems: a study protocol. | Ebenau A et al. | β | 2018 | β |
| Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. | Bahorik AL et al. | β | 2017 | β |
| Drinking Status Between Ages 50 and 55 for Men From the San Diego Prospective Study Who Developed DSM-IV Alcohol Abuse or Dependence in Prior Follow-Ups. | GonΓ§alves PD et al. | β | 2017 | β |
| Familial association of abstinent remission from alcohol use disorder in first-degree relatives of alcohol-dependent treatment-seeking probands. | McCutcheon VV et al. | β | 2017 | β |
| Harm reduction-a systematic review on effects of alcohol reduction on physical and mental symptoms. | Charlet K et al. | β | 2017 | β |
| Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence? | Mann K et al. | β | 2017 | β |
| Alcohol Dependence and Harmful Use of Alcohol. | Batra A et al. | β | 2016 | β |
| Nucleus accumbens core and shell are differentially involved in general and outcome-specific forms of Pavlovian-instrumental transfer with alcohol and sucrose rewards. | Corbit LH et al. | β | 2016 | β |
| Remission from substance use disorders: A systematic review and meta-analysis. | Fleury MJ et al. | β | 2016 | β |
| The six-year outcome of alcohol use disorders in men: A population based study from India. | Nadkarni A et al. | β | 2016 | β |
| Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment. | Schellekens AF et al. | β | 2015 | β |
| Injury-Related Mortality Over 12Β Years in a Cohort of Patients with Alcohol Use Disorders: Higher Mortality Among Young People and Women. | Guitart AM et al. | β | 2015 | β |
| The effects of compound stimulus extinction and inhibition of noradrenaline reuptake on the renewal of alcohol seeking. | Furlong TM et al. | β | 2015 | β |
| Alcohol abstinence, non-hazardous use and hazardous use a decade after alcohol-related hospitalization: registry data linked to population-based representative postal surveys. | Ahacic K et al. | β | 2014 | β |
| Alcoholism risk reduction in France: a modernised approach related to alcohol misuse disorders. | Brousse G et al. | β | 2014 | β |
| Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis. | Jonas DE et al. | β | 2014 | β |
| Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain. | Sanvisens A et al. | β | 2014 | β |
| Clinical and laboratory predictors of all causes deaths and alcohol-attributable deaths among discharged alcohol-dependent patients. | Park S et al. | β | 2013 | β |
| Excess mortality of alcohol-dependent individuals after 14Β years and mortality predictors based on treatment participation and severity of alcohol dependence. | John U et al. | β | 2013 | β |
| Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders. | Rivas I et al. | β | 2013 | β |
| Improved drinking behaviour improves quality of life: a follow-up in alcohol-dependent subjects 7 years after treatment. | Frischknecht U et al. | β | 2013 | β |
| Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. | van Amsterdam J et al. | β | 2013 | β |
| The course and outcome of alcohol use disorders in men in Goa: A population- based follow-up study. | Nadkarni A et al. | β | 2013 | β |
| Factors related to recent alcohol abstinence among individuals who received previous treatment. | Ahmedani BK et al. | β | 2012 | β |
| Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals. | Fahlke C et al. | β | 2012 | β |
| Prognostic factors during outpatient treatment for alcohol dependence: cohort study with 6 months of treatment follow-up. | Aguiar P et al. | β | 2012 | β |
| Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. | Dahlgren A et al. | β | 2011 | β |
| Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial. | VollstΓ€dt-Klein S et al. | β | 2011 | β |
| Onset and course of alcoholism over 25 years in middle class men. | Schuckit MA et al. | β | 2011 | β |
| Persistence of addictive disorders in a first-offender driving while impaired population. | Lapham SC et al. | β | 2011 | β |
| Recurring alcohol-related care between 1998 and 2007 among people treated for an alcohol-related disorder in 1997: a register study in Stockholm County. | Ahacic K et al. | β | 2011 | β |
| Addiction research centres and the nurturing of creativityβ¨department of addictive behaviour and addiction medicine, central institute of Mental Health, Mannheim, University of Heidelberg. | Mann K | β | 2010 | β |
| Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals. | Berggren U et al. | β | 2010 | β |
| Alcohol-use disorders. | Schuckit MA | β | 2009 | β |
| Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. | Wojnar M et al. | β | 2009 | β |
| Complementary and alternative medicine in the treatment of substance use disorders--a review of the evidence. | Behere RV et al. | β | 2009 | β |
| Complete suppression of craving in alcohol-dependent individuals: is it possible? | Kiefer F | β | 2009 | β |
| Striving for abstinence in alcoholic pancreatitis: act of humanity, economic necessity, or flogging a dead horse after all? | Singer MV et al. | β | 2009 | β |
| Treatment for alcohol dependence in Catalonia: health outcomes and stability of drinking patterns over 20 years in 850 patients. | Gual A et al. | β | 2009 | β |
| [Treatment outcome after inpatient alcohol withdrawal: impact of motivational interventions: a comparative study]. | Loeber S et al. | β | 2009 | β |
| Asking the right questions in the right way: the need for a shift in research on psychological treatments for addiction. | Orford J | β | 2008 | β |
| Impulsive suicide attempts predict post-treatment relapse in alcohol-dependent patients. | Wojnar M et al. | β | 2008 | β |
| [Pharmacological relapse prevention in alcohol and tobacco dependence]. | Diehl A et al. | β | 2007 | β |
| Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up. | Dawson DA et al. | β | 2007 | β |
| Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties. | Landheim AS et al. | β | 2006 | β |
| [The development of evidence-based psychotherapy for use in alcoholism. A review]. | Loeber S et al. | β | 2006 | β |
| Transplantation for alcoholic liver disease: report of a consensus meeting. | Webb K et al. | β | 2006 | β |
| Worldwide alcohol-related research and the disease burden. | Rajendram R et al. | β | 2006 | β |